BridgeBio Oncology Therapeutics, Inc. Common Stock
XNAS:BBOT
11.25
$11.53 - 3.00
$11.12 - 3.00
$
Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 381
0
Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 381
0
$
Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 382
0
Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 382
0
$
Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 383
0
Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 383
0
$11.25
14.87
8.5
0
394613.9
43545531.67
Chart
TendieTensor AI Analysis
Company
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
Fundamentals
-12.130000
1.994540
100
BBG01L3GYF02
BBG01L3GYF11
79.20M
79.20M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own BBOT. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.